Drug intelligence / Profile preview

[123I]-CNS 1261

Development stage
Preclinical
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

[123I]-CNS 1261 is a radiolabeled ligand used as a SPECT (Single Photon Emission Computed Tomography) imaging agent for the NMDA (N-methyl-D-aspartate) receptor, specifically binding to the MK801 intrachannel site. It is primarily utilized in research settings to study glutamatergic neurotransmission and NMDA receptor function in the human brain. The tracer allows for non-invasive quantification of NMDA receptor availability and has been investigated in neuropsychiatric disorders such as schizophrenia. Studies have shown that global binding of [123I]-CNS 1261 can be altered by antipsychotic treatment, indicating its potential utility in monitoring disease state or drug effects on glutamatergic systems[1][3][4].

Other names
[(123)I]CNS 1261[123I] CNS-1261Iodine-123 CNS-1261Iodine123 CNS-1261Iodine 123 CNS-1261
02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on [123I]-CNS 1261.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [123I]-CNS 1261.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call